In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today
The number of anticancer immunotherapeutics approved by the U.S. Food and Drug Administration (FDA) is rising rapidly. In fact,...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
Earlier this week, new ground was broken in the field of cancer immunotherapy when the U.S. Food and Drug...
Among the many types of cancer acknowledged during the month of September is lymphoma, a cancer arising from a...
Last week, the U.S. Food and Drug Administration (FDA) approved a new combination of drugs, formulated together in a...
Later today, more than 200 scientists working diligently to advance the field of epigenetics research will convene in Atlanta...
Government task force drafts recommendations for low-dose aspirin for the prevention of cardiovascular disease and colorectal cancer; a study...
The inaugural International Cancer Immunotherapy Conference, hosted jointly by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy...
By AACR President José Baselga, MD, PhD, and AACR CEO Margaret Foti, PhD, MD (hc)